<DOC>
	<DOCNO>NCT01923519</DOCNO>
	<brief_summary>The respiratory epithelium play lead role development allergic respiratory disease barrier function alteration , repair mechanism , anti-viral fight ability induce Th2 response . The majority allergic asthmatic patient reach concomitant ENT : concept `` one airway , one disease . '' Access material epithelial study different phenotype disease appear crucial . Nasal bronchial epithelial tissue reveal essential difference particular related environment ( remodel less intense low sensitivity virus nose ) , nevertheless share many common cellular characteristic .</brief_summary>
	<brief_title>Study Genic Expression Profiles Epithelium Nose Bronchi Healthy Allergic Subjects</brief_title>
	<detailed_description />
	<criteria>age â‰¥ 18 year &lt; 30 year isolate allergic rhinitis accord clinical criterion ARIA absence asthma whose diagnosis make base clinical criterion mild moderate persistent asthma control diagnosis make base clinical criterion recent rhinobronchial infection ( &lt; 6 week ) asthma exacerbation previous 6 week Chronic disease may opinion investigator interfere result study expose additional risk . Treatment nasal corticosteroid , inhale systemic past 6 week Current smoke history smoke smoke least 12 month wean smoke history &lt; 5 packyears ) Special Needs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>